Oxford Immunocore (nasdaq: Imcr)

Details

  • Number of employees
    100-500
  • Company Type
    Large Multi-national
About Oxford Immunocore (nasdaq: Imcr)

Oxford Immunocore (nasdaq: Imcr) is a biotechnology company focused on developing innovative therapies for chronic infections and unmet medical needs. The company specializes in the application of its ImmTAX® platform to create novel treatments, particularly for diseases such as HIV, HBV, and EBV-associated conditions.

Career Opportunities

Oxford Immunocore offers a dynamic working environment that fosters professional growth and collaboration among scientists. The company values diversity and inclusion, providing employees with opportunities to contribute to groundbreaking research and development.

  • Collaborative and innovative work culture
  • Opportunities for professional development and advancement
  • Focus on impactful research in the field of immunotherapy
>